Zydus receives final approval from the USFDA for Minocycline Hydrochloride Extended-Release Tablets

Zydus receives final approval from the USFDA for Minocycline Hydrochloride Extended-Release Tablets

The product will be manufactured at the group’s formulation manufacturing facility in Moraiya, Ahmedabad (India).

FPJ Web DeskUpdated: Monday, June 19, 2023, 03:43 PM IST
article-image
Zydus receives final approval from the USFDA for Minocycline Hydrochloride Extended-Release Tablets | Image: Zydus (Representative)

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for Minocycline Hydrochloride Extended-Release Tablets USP, 55 mg, 65 mg, and 115 mg.

Minocycline Hydrochloride Extended-Release is used to treat moderate to severe acne in people 12 years and older. Minocycline belongs to a class of drugs known as tetracycline antibiotics. The product will be manufactured at the group’s formulation manufacturing facility in Moraiya, Ahmedabad (India).

Minocycline Hydrochloride Extended-Release Tablets USP, 55 mg, 65 mg, and 115 mg had annual sales of USD 0.7 mn in the United States.

The group now has 372 approvals and has so far filed over 442* ANDAs since the commencement of the filing process in FY 2003-04.

RECENT STORIES

Mahindra Logistics To Raise ₹750 Crore Via Rights Issue, Focus On Growth & Debt Reduction

Mahindra Logistics To Raise ₹750 Crore Via Rights Issue, Focus On Growth & Debt Reduction

Shares Of Glenmark Pharmaceuticals Jump 10% After Deal With AbbVie; USD 2 Billion To Commercialise...

Shares Of Glenmark Pharmaceuticals Jump 10% After Deal With AbbVie; USD 2 Billion To Commercialise...

IPO: INOX Clean Energy To Raise ₹6,000 Crore, Potential To Be Largest Indian IPO

IPO: INOX Clean Energy To Raise ₹6,000 Crore, Potential To Be Largest Indian IPO

Gautam Adani Urges Medical Innovation, Backs Healthcare Transformation With ₹60,000 Cr Vision

Gautam Adani Urges Medical Innovation, Backs Healthcare Transformation With ₹60,000 Cr Vision

IT Department Launches ITR-2 & ITR-3 Excel Utilities, Filing Now Easier For Capital Gains & Crypto...

IT Department Launches ITR-2 & ITR-3 Excel Utilities, Filing Now Easier For Capital Gains & Crypto...